Valentino LA - Search Results

1

Race and ethnicity reporting and representation in hemophilia clinical trials.

Fedewa SA, Valentino LA, Koo A, Cafuir L, Tran DQ, Antun A, Kempton CL. Fedewa SA, et al. Among authors: valentino la. Blood Adv. 2024 May 28;8(10):2351-2360. doi: 10.1182/bloodadvances.2024012862. Blood Adv. 2024. PMID: 38547444

2

Changes in bleeding patterns in von Willebrand disease after institution of long-term replacement therapy: results from the von Willebrand Disease Prophylaxis Network.

Holm E, Abshire TC, Bowen J, Álvarez MT, Bolton-Maggs P, Carcao M, Federici AB, Gill JC, Halimeh S, Kempton C, Key NS, Kouides P, Lail A, Landorph A, Leebeek F, Makris M, Mannucci P, Mauser-Bunschoten EP, Nugent D, Valentino LA, Winikoff R, Berntorp E. Holm E, et al. Among authors: valentino la. Blood Coagul Fibrinolysis. 2015 Jun;26(4):383-8. doi: 10.1097/MBC.0000000000000257. Blood Coagul Fibrinolysis. 2015. PMID: 25688461 Clinical Trial.

3

Factor VIII prophylaxis effects outweigh other hemostasis contributors in predicting severe haemophilia A joint outcomes.

Warren BB, Jacobson L, Kempton C, Buchanan GR, Recht M, Brown D, Leissinger C, Shapiro AD, Abshire TC, Manco-Johnson MJ; Joint Outcome Study Group Investigators. Warren BB, et al. Haemophilia. 2019 Sep;25(5):867-875. doi: 10.1111/hae.13778. Epub 2019 May 21. Haemophilia. 2019. PMID: 31115111 Free PMC article.

4

Discussing investigational AAV gene therapy with hemophilia patients: A guide.

Sidonio RF Jr, Pipe SW, Callaghan MU, Valentino LA, Monahan PE, Croteau SE. Sidonio RF Jr, et al. Among authors: valentino la. Blood Rev. 2021 May;47:100759. doi: 10.1016/j.blre.2020.100759. Epub 2020 Nov 10. Blood Rev. 2021. PMID: 33183859 Review.

5

Integrated Hemophilia Patient Care via a National Network of Care Centers in the United States: A Model for Rare Coagulation Disorders.

Valentino LA, Baker JR, Butler R, Escobar M, Frick N, Karp S, Koulianos K, Lattimore S, Nugent D, Pugliese JN, Recht M, Reding MT, Rice M, Thibodeaux CB, Skinner M. Valentino LA, et al. J Blood Med. 2021 Oct 21;12:897-911. doi: 10.2147/JBM.S325031. eCollection 2021. J Blood Med. 2021. PMID: 34707421 Free PMC article.

6

Venous access in the management of hemophilia.

Valentino LA, Kawji M, Grygotis M. Valentino LA, et al. Blood Rev. 2011 Jan;25(1):11-5. doi: 10.1016/j.blre.2010.10.001. Epub 2010 Oct 27. Blood Rev. 2011. PMID: 21030121 Review.

7

A preventive approach to the management of severe hemophilia A.

Valentino LA. Valentino LA. Clin Adv Hematol Oncol. 2012 Mar;10(3):185-6. Clin Adv Hematol Oncol. 2012. PMID: 22402427 No abstract available.

8

Pathobiology of hemophilic synovitis I: overexpression of mdm2 oncogene.

Hakobyan N, Kazarian T, Jabbar AA, Jabbar KJ, Valentino LA. Hakobyan N, et al. Among authors: valentino la. Blood. 2004 Oct 1;104(7):2060-4. doi: 10.1182/blood-2003-12-4231. Epub 2004 Jun 1. Blood. 2004. PMID: 15172967 Free article.

9

c-myc proto-oncogene expression in hemophilic synovitis: in vitro studies of the effects of iron and ceramide.

Wen FQ, Jabbar AA, Chen YX, Kazarian T, Patel DA, Valentino LA. Wen FQ, et al. Among authors: valentino la. Blood. 2002 Aug 1;100(3):912-6. doi: 10.1182/blood-2002-02-0390. Blood. 2002. PMID: 12130502 Free article.

10

Hemophilia: in review.

Zimmerman B, Valentino LA. Zimmerman B, et al. Among authors: valentino la. Pediatr Rev. 2013 Jul;34(7):289-94; quiz 295. doi: 10.1542/pir.34-7-289. Pediatr Rev. 2013. PMID: 23818083 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

146 results

Search Page